Cortes J - Search Results

1

Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.

Sacchi S, Kantarjian HM, Freireich EJ, O'Brien S, Cortes J, Rios MB, Kornblau S, Giles FJ, Koller C, Gajewski J, Talpaz M. Sacchi S, et al. Among authors: cortes j. Leuk Lymphoma. 1999 Nov;35(5-6):483-9. doi: 10.1080/10428199909169612. Leuk Lymphoma. 1999. PMID: 10609785 Clinical Trial.

2

Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.

Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich EJ, Keating M, Pierce S, Estey E. Cortes J, et al. Leukemia. 1994 Dec;8(12):2174-8. Leukemia. 1994. PMID: 7808007

3

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M. Cortes J, et al. Am J Med. 1996 Apr;100(4):452-5. doi: 10.1016/s0002-9343(97)89522-8. Am J Med. 1996. PMID: 8610733 Clinical Trial.

4

Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Sarris A, et al. Among authors: cortes j. Leuk Lymphoma. 1996 Mar;21(1-2):85-92. doi: 10.3109/10428199609067584. Leuk Lymphoma. 1996. PMID: 8907274

5

Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabine.

Cortes J, Kantarjian H, Talpaz M, O'Brien S, Beran M, Koller C, Keating M. Cortes J, et al. Leukemia. 1997 Jun;11(6):788-91. doi: 10.1038/sj.leu.2400677. Leukemia. 1997. PMID: 9177428 Clinical Trial.

6

A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Cortes J, Kantarjian H, O'Brien S, Beran M, Estey E, Keating M, Talpaz M. Cortes J, et al. Leukemia. 1997 Jul;11(7):929-32. doi: 10.1038/sj.leu.2400682. Leukemia. 1997. PMID: 9204970

7

Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia.

Bseiso AW, Kantarjian HM, Guo JQ, Cortes J, Talpaz M, Koller C, AlBitar M, Keating M, Arlinghaus R. Bseiso AW, et al. Among authors: cortes j. Leukemia. 1997 Sep;11(9):1583-7. doi: 10.1038/sj.leu.2400752. Leukemia. 1997. PMID: 9305617

8

Natural history and staging of chronic myelogenous leukaemia.

Cortes J, Kantarjian HM, Giralt S, Talpaz M. Cortes J, et al. Baillieres Clin Haematol. 1997 Jun;10(2):277-90. doi: 10.1016/s0950-3536(97)80007-8. Baillieres Clin Haematol. 1997. PMID: 9376664 Review.

9

Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia.

Sacchi S, Cortes J, Kantarjian H, Talpaz M. Sacchi S, et al. Among authors: cortes j. Hematopathol Mol Hematol. 1997-1998;11(1):41-7. Hematopathol Mol Hematol. 1997. PMID: 9439979

10

Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia.

Cortes J, Fayad L, Kantarjian H, O'Brien S, Lee MS, Talpaz M. Cortes J, et al. Leukemia. 1998 Apr;12(4):455-62. doi: 10.1038/sj.leu.2400965. Leukemia. 1998. PMID: 9557601 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,836 results

Search Page

Filters